Safety of a New Security Device in Patients With Implanted Cardiac Electronic Devices

Deutsches Herzzentrum Muenchen379 enrolled

Overview

Patients with implantable cardiac electronic devices will be exposed to a new safety device and evaluated for potential electromagnetic interference.

Patients with implanted pacemakers or defibrillators will undergo a screening procedure with an innovative security device. Evaluation will be made with respect to the occurrence of interference.

Study Type

INTERVENTIONAL

Allocation

Purpose

PREVENTION

Masking

NONE

Enrollment

379

Conditions

Electromagnetic Interference

Interventions

Security screening procedureOTHER

Screening procedure with security device (model QPS 100)

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * implantable pacemaker or defibrillator in situ Exclusion Criteria: * malfunction of implantable pacemaker or defibrillator * low battery voltage of implanted cardiac electronic device

Locations (1)

Deutsches Herzzentrum München

Munich, Bavaria, Germany

Outcomes

Primary Outcomes

Electromagnetic interference

Occurrence of electromagnetic interference

Time frame: 10 minutes

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.